Health CanadaGeneral Alert
Archived – Serious Adverse Reactions in Pediatric Patients Treated with ORTHOCLONE OKT*3 (muromonab-CD3) – Notice to Hospitals
Published: May 13, 2004Recall ID: 24536Category: generalCountry: Canada
Safety AlertHealth Canada
Canada
Archived – Serious Adverse Reactions in Pediatric Patients Treated with ORTHOCLONE OKT*3 (muromonab-CD3) – Notice to Hospitals
Recalling Firm: Marketed health products
Reason for Recall / Hazard
Product safety
Product Description & Identification
Archived – Serious Adverse Reactions in Pediatric Patients Treated with ORTHOCLONE OKT*3 (muromonab-CD3) – Notice to Hospitals
Additional Source Details
| Field | Value |
|---|---|
| N I D | 24536 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/archived-serious-adverse-reactions-pediatric-patients-treated-orthoclone-okt3 |
| Issue | Product safety |
| Title | Archived – Serious Adverse Reactions in Pediatric Patients Treated with ORTHOCLONE OKT*3 (muromonab-CD3) – Notice to Hospitals |
| Archived | 1 |
| Category | Biologic or vaccine |
| Last updated | 2004-05-13 |
| Organization | Marketed health products |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmMarketed health products
Recall Hazard Severity
Official Agency AlertCaution (Class III)
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Marketed health products - Archived – Serious Adverse Reactions in Pediatric Patients Treated with ORTHOCLONE OKT*3 (muromonab-CD3) – Notice to Hospitals Check if your household is affected: https://therecallfile.com/recalls/archived-serious-adverse-reactions-in-pediatric-patients-treated-with/CANADA-24536
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.
Spread the WordArchived – Serious Adverse Reactions in Pediatric Patients Treated with ORTHOCLONE OKT*3 (muromonab-CD3) – Notice to Hospitals